Amid COVID-19 worries, PM Narendra Modi s Denmark visit for second India-Nordic Summit cancelled india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.
India unlikely to resume sizable COVID-19 vaccine exports until October: Sources
SECTIONS
Last Updated: May 18, 2021, 12:57 PM IST
Share
Synopsis
Battling the world s biggest jump in coronavirus infections, India halted vaccine exports a month ago after donating or selling more than 66 million doses.
AP
WHO, which co-leads COVAX, called on vaccine makers outside India to advance supplies to the programme given the shortfall from the South Asian country.
India is unlikely to resume major exports of COVID-19 vaccines until at least October as it diverts shots for domestic use, three government sources said, a longer-than-expected delay set to worsen supply shortages from the global COVAX initiative.
Exclusive-India unlikely to resume sizable COVID-19 vaccine exports until October -sources
By Rupam Jain, Neha Arora and Krishna N. Das
Reuters
NEW DELHI (Reuters) - India is unlikely to resume major exports of COVID-19 vaccines until at least October as it diverts shots for domestic use, three government sources said, a longer-than-expected delay set to worsen supply shortages from the global COVAX initiative.
Battling the world s biggest jump in coronavirus infections, India halted vaccine exports a month ago after donating or selling more than 66 million doses. The move has left countries including Bangladesh, Nepal, Sri Lanka and many in Africa scrambling for alternate supplies.
Why 20 million U S doses is good news for vaccine equity, but not nearly enough to close the vaccine gap washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.